Fri Sep 20 09:14:51 UTC 2024: ## Quanterix Director Makes Significant Stock Purchase, Boosting Confidence in Company

**[City, State] -** Quanterix Co. (NASDAQ: QTRX) saw a significant vote of confidence this week as Director David R. Walt purchased 47,000 shares of the company’s stock on August 20th. The transaction, disclosed in a legal filing with the SEC, totaled $624,630.00, with shares purchased at an average price of $13.29.

Following the purchase, Walt now owns 1,487,342 shares of Quanterix, valued at $19,766,775.18. This insider purchase signals a strong belief in the company’s future prospects and potential for growth.

Quanterix, a life sciences company, develops and markets digital immunoassay platforms for precision health research and diagnostics. The company’s recent quarterly earnings report, released on August 8th, showed revenue of $34.38 million, narrowly beating analyst expectations. However, the company reported a loss of $0.25 per share, missing estimates by $0.02.

Despite the mixed earnings, several hedge funds have recently increased their holdings in Quanterix, indicating a positive outlook on the company’s long-term potential.

Quanterix’s stock opened at $15.49 on Friday, with a market cap of $592.80 million. The company’s 50-day moving average price is $13.43, while its 200-day moving average price is $16.54.

**[This article was compiled using information from MarketBeat News and does not constitute financial advice.]**

Read More